NFKB1 and viral pneumonia: Overall, these natural products can effectively alleviate the immune pathological responses caused by viruses by targeting key nodes of NF-κB, regulating ROS interactions, or jointly blocking downstream inflammatory networks, providing diverse and stable candidate options for the adjuvant treatment of viral pneumonia.